SCHEMBL8019790

SCHEMBL8019790

CC(C)(C)OC(=O)C1(OC=O)CCC(CN)CC1

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PLG P00747 1/20 0.31
PLAT P00750 1/20 0.31
LMNA P02545 1/20 0.31
GPR119 Q8TDV5 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4743034 0.78 CYP4F2 (0.32)
SCHEMBL7972576 0.75 PLG (0.37) PLGPLATLMNA
SCHEMBL8597693 0.72
SCHEMBL8145030 0.71 DGAT1 (0.35)
SCHEMBL6673585 0.70 NAMPT (0.30)
Hydrochloric Acid SCHEMBL8596533 0.69 DPP4 (0.34)
SCHEMBL24693734 0.69 GPR119 (0.55) GPR119
SCHEMBL28958600 0.68 PLG (0.42) PLGPLATLMNA
SCHEMBL13668662 0.68 PLG (0.42) PLGPLATLMNA
SCHEMBL4483887 0.68 KMT2A (0.38) PLGPLATLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0763016-B1 COMPOSITIONS AND METHODS FOR TREATING MAST-CELL MEDIATED CONDITIONS AXYS PHARM INC (US) 2000-01-26 EP disclosed
US-5656660-A AMINE OR GUANIDINE GROUP-CONTAINING TRYPTASE INHIBITOR ARRIS PHARMACEUTICAL CORPORATION (US) 1997-08-12 US disclosed